AIXTRON Second Quarter 2025 Earnings: Revenues Beat Expectations
Key Financial Results
Revenue: €137.4m (up 4.3% from 2Q 2024).
Net income: €19.2m (up 73% from 2Q 2024).
Profit margin: 14% (up from 8.4% in 2Q 2024). The increase in margin was primarily driven by higher revenue.
This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.
All figures shown in the chart above are for the trailing 12 month (TTM) period
AIXTRON Revenues Beat Expectations
Revenue exceeded analyst estimates by 3.6%.
Looking ahead, revenue is forecast to grow 6.1% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Semiconductor industry in Germany.
Performance of the German Semiconductor industry.
The company's shares are down 6.3% from a week ago.
Balance Sheet Analysis
Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on AIXTRON's balance sheet health.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Ocugen Second Quarter 2025 Earnings: Beats Expectations
Ocugen (NASDAQ:OCGN) Second Quarter 2025 Results Key Financial Results Revenue: US$1.37m (up 20% from 2Q 2024). Net loss: US$14.7m (loss narrowed by 3.5% from 2Q 2024). US$0.05 loss per share (improved from US$0.059 loss in 2Q 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Ocugen Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates significantly. Earnings per share (EPS) also surpassed analyst estimates by 12%. Looking ahead, revenue is forecast to grow 71% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Biotechs industry in the US. Performance of the American Biotechs industry. The company's shares are down 8.8% from a week ago. Risk Analysis It's necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Ocugen (at least 1 which is a bit concerning), and understanding them should be part of your investment process. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati
Yahoo
16 minutes ago
- Yahoo
Manchester United prepared to match Newcastle bid for Šeško, per Sky Germany
After it was reported last night that RB Leipzig rejected Newcastle United's first bid for Benjamin Šeško, talks have resumed today. Sky Germany's intel suggests negotiations have been continuing since early this morning, August 3, with Šeško's agents still in Leipzig. Furthermore, fellow Premier League club Manchester United, who are also keen on the Slovenian, are ready to match Newcastle's offer. Everything depends on the 22-year-old's decision, therefore the situation is ideal for Leipzig who would welcome a possible bidding war. Newcastle's offer of €75million plus €5million in bonuses was attractive for Leipzig – but the payment structure would need to be adjusted.
Yahoo
41 minutes ago
- Yahoo
Who could lead Apple after Tim Cook
There are no indications that Apple (AAPL) CEO Tim Cook is planning on leaving his role anytime soon. But the company's underwhelming AI developments have some questioning if it's time for new leadership. Yahoo Finance Tech Editor Dan Howley takes a closer look at some of the potential contenders. To watch more expert insights and analysis on the latest market action, check out more Market Domination. Related videos £50k in savings? Here's how to unlock up to £4.5k in passive income overnight Down 55% in 5 years, but this FTSE stock offers a 9.5% dividend yield for income investors! How will the Lloyds share price be affected by today's Supreme Court ruling? Meet the 75p dividend stock with a higher yield than Legal & General shares Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
